153 related articles for article (PubMed ID: 34419617)
21. Can the FUT2
Giampaoli O; Conta G; Calvani R; Miccheli A
Front Nutr; 2020; 7():606171. PubMed ID: 33425974
[TBL] [Abstract][Full Text] [Related]
22. Dynamic immunoglobulin responses to gut bacteria during inflammatory bowel disease.
Rengarajan S; Vivio EE; Parkes M; Peterson DA; Roberson EDO; Newberry RD; Ciorba MA; Hsieh CS
Gut Microbes; 2020 May; 11(3):405-420. PubMed ID: 31203722
[TBL] [Abstract][Full Text] [Related]
23. Multigenerational Influences of the
Rausch P; Künzel S; Suwandi A; Grassl GA; Rosenstiel P; Baines JF
Front Microbiol; 2017; 8():991. PubMed ID: 28642740
[TBL] [Abstract][Full Text] [Related]
24. Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
Chehoud C; Albenberg LG; Judge C; Hoffmann C; Grunberg S; Bittinger K; Baldassano RN; Lewis JD; Bushman FD; Wu GD
Inflamm Bowel Dis; 2015 Aug; 21(8):1948-56. PubMed ID: 26083617
[TBL] [Abstract][Full Text] [Related]
25. The Intestinal Microbiota in Inflammatory Bowel Disease.
Becker C; Neurath MF; Wirtz S
ILAR J; 2015; 56(2):192-204. PubMed ID: 26323629
[TBL] [Abstract][Full Text] [Related]
26. Association of Alterations in Intestinal Microbiota With Impaired Psychological Function in Patients With Inflammatory Bowel Diseases in Remission.
Humbel F; Rieder JH; Franc Y; Juillerat P; Scharl M; Misselwitz B; Schreiner P; Begré S; Rogler G; von Känel R; Yilmaz B; Biedermann L;
Clin Gastroenterol Hepatol; 2020 Aug; 18(9):2019-2029.e11. PubMed ID: 31546058
[TBL] [Abstract][Full Text] [Related]
27. Characterization of the gut microbiota in patients with primary sclerosing cholangitis compared to inflammatory bowel disease and healthy controls.
Ostadmohammadi S; Azimirad M; Houri H; Naseri K; Javanmard E; Mirjalali H; Yadegar A; Sadeghi A; Asadzadeh Aghdaei H; Zali MR
Mol Biol Rep; 2021 Jul; 48(7):5519-5529. PubMed ID: 34304365
[TBL] [Abstract][Full Text] [Related]
28. Gut mycobiome: The probable determinative role of fungi in IBD patients.
Beheshti-Maal A; Shahrokh S; Ansari S; Mirsamadi ES; Yadegar A; Mirjalali H; Zali MR
Mycoses; 2021 May; 64(5):468-476. PubMed ID: 33421192
[TBL] [Abstract][Full Text] [Related]
29. Similar Depletion of Protective Faecalibacterium prausnitzii in Psoriasis and Inflammatory Bowel Disease, but not in Hidradenitis Suppurativa.
Eppinga H; Sperna Weiland CJ; Thio HB; van der Woude CJ; Nijsten TE; Peppelenbosch MP; Konstantinov SR
J Crohns Colitis; 2016 Sep; 10(9):1067-75. PubMed ID: 26971052
[TBL] [Abstract][Full Text] [Related]
30. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
[TBL] [Abstract][Full Text] [Related]
31. Distinct gut microbiota profiles in patients with primary sclerosing cholangitis and ulcerative colitis.
Bajer L; Kverka M; Kostovcik M; Macinga P; Dvorak J; Stehlikova Z; Brezina J; Wohl P; Spicak J; Drastich P
World J Gastroenterol; 2017 Jul; 23(25):4548-4558. PubMed ID: 28740343
[TBL] [Abstract][Full Text] [Related]
32. Role of exercise in preventing and restoring gut dysbiosis in patients with inflammatory bowel diseases: A review.
Koutouratsas T; Philippou A; Kolios G; Koutsilieris M; Gazouli M
World J Gastroenterol; 2021 Aug; 27(30):5037-5046. PubMed ID: 34497433
[TBL] [Abstract][Full Text] [Related]
33. Review article: fungal alterations in inflammatory bowel diseases.
Lam S; Zuo T; Ho M; Chan FKL; Chan PKS; Ng SC
Aliment Pharmacol Ther; 2019 Dec; 50(11-12):1159-1171. PubMed ID: 31648369
[TBL] [Abstract][Full Text] [Related]
34. Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.
McIlroy J; Ianiro G; Mukhopadhya I; Hansen R; Hold GL
Aliment Pharmacol Ther; 2018 Jan; 47(1):26-42. PubMed ID: 29034981
[TBL] [Abstract][Full Text] [Related]
35. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
36. Role of antibiotics for treatment of inflammatory bowel disease.
Nitzan O; Elias M; Peretz A; Saliba W
World J Gastroenterol; 2016 Jan; 22(3):1078-87. PubMed ID: 26811648
[TBL] [Abstract][Full Text] [Related]
37. Inflammatory bowel disease: tri-directional relationship between microbiota, immune system and intestinal epithelium.
Ahlawat S; Kumar P; Mohan H; Goyal S; Sharma KK
Crit Rev Microbiol; 2021 Mar; 47(2):254-273. PubMed ID: 33576711
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered.
Qiao YQ; Cai CW; Ran ZH
J Dig Dis; 2016 Dec; 17(12):800-810. PubMed ID: 27743467
[TBL] [Abstract][Full Text] [Related]
39. Combined analysis of metagenomic data revealed consistent changes of gut microbiome structure and function in inflammatory bowel disease.
Xia Y; Wang J; Fang X; Dou T; Han L; Yang C
J Appl Microbiol; 2021 Dec; 131(6):3018-3031. PubMed ID: 34008889
[TBL] [Abstract][Full Text] [Related]
40. [Oral microbiota and inflammatory bowel disease].
Zhang HN; Zhou XD; Xu X; Wang Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2019 Aug; 37(4):443-449. PubMed ID: 31512842
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
